AbbVie



Ebitda تغيير تاريخ
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.18B 486M 2025-03
ALKERMES USD 21.21M 142.21M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
J&J USD 7.88B 1.76B 2025-03
Medtronic USD 2.44B 134M 2025-01
Merck USD 7.74B 625M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pacira USD 50.78M 8.5M 2024-12
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
UCB EUR 652M 105M 2024-06
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
United Therapeutics USD 402.6M 19.2M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Zoetis USD 894M 145M 2024-12



AbbVie - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.